MacroGenics (MGNX) Earnings Analysis
MacroGenics (MGNX) next reports earnings on 2026-08-13, consensus EPS 0.02583 USD. Last quarter (2026-03-09) it beat with EPS -0.22 USD vs -0.42 USD est (+47.6%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -3.91.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MGNX next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | 0.02583 USD |
| Revenue estimate | 0.07B |
MGNX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-09 | -0.22 USD | -0.42 USD | +47.6% | Beat |
| 2025-11-12 | 0.27 USD | -0.48 USD | +156.3% | Beat |
| 2025-08-14 | -0.57 USD | -0.59 USD | +3.4% | Beat |
| 2025-03-20 | -0.25 USD | -0.23 USD | -8.7% | Miss |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
MGNX valuation and analyst view
| Trailing P/E | -3.91 |
|---|---|
| Trailing EPS | -1.10888 USD |
| Price / book | 12.87 |
| Dividend yield | 0.00% |
| Market cap | 0.28B |
| Analyst consensus | Buy (12 buy / 9 hold / 1 sell) |
| Avg price target | 6 USD |
Related research pages
Frequently asked questions
When is MacroGenics (MGNX)'s next earnings date?
MacroGenics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of 0.02583 USD and revenue estimate of 0.07B.
Did MGNX beat earnings last quarter?
In its 2026-03-09 report, MGNX posted EPS of -0.22 USD versus a -0.42 USD estimate — a beat of 47.6%.
What is MGNX's earnings track record?
Over the last 4 reported quarters with consensus data, MGNX beat estimates 3 times (75%).
What is MGNX's current P/E ratio and EPS?
MGNX trades at a trailing P/E of -3.91 on trailing EPS of -1.1088769732534927 USD.
What do analysts rate MGNX?
Analyst consensus is "Buy" across 22 ratings (0 strong buy, 12 buy, 9 hold, 1 sell, 0 strong sell). Average 12-month price target: 6 USD.